Table 5 Treatment outcomes
From: Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB)
Mean +/− SD or N (%) | |
|---|---|
Time to culture conversion (months) | 1.7 ± 1.2 |
Successful treatment outcome (cure/treatment completion) | 41 (84%) |
Loss to follow up/not evaluated | 6 (12%) |
Treatment failure/relapse | 1 (2%) |
Death | 1 (2%) |